Please provide your email address to receive an email when new articles are posted on . Using a combination of nicotine replacement therapy and varenicline may be more effective as first-line therapy ...
A phase II trial of trastuzumab plus modified-FOLFOX for gemcitabine/cisplatin refractory HER2-positive biliary tract cancer (BTC): Multi-institutional study of the Korean Cancer Study Group ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results